Moderna ha vaccinato i primi partecipanti a una sperimentazione sul vaccino contro il ceppo Bundibugyo dell’Ebola, mentre la RDCongo affronta il suo focolaio in crescita più rapida mai registrato.

Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines indicatedPhase 1 trial is being conducted in Canada as part of…

TORONTO - Health Canada has authorized Moderna to conduct a clinical trial on a new mRNA vaccine that targets the form of Ebola blamed for the largest outbreak ever reported